Recently, several industry executives and experts have indicated that international pharmaceutical companies are trying to reduce their dependence on China, with Indian drug manufacturers emerging as a better option. For nearly 20 years, mainland China has been an ideal location for the development and manufacturing of new drugs by major international pharmaceutical companies, thanks to the low cost and fast speed of its Contract Development and Manufacturing Organization (CDMO) services. #pharmacy #chinaobserver All rights reserved.
